Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors

The severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) survivors are more likely to produce a potent immune response to SARS-CoV-2 after booster vaccination. We assessed humoral and T cell responses against SARS-CoV-2 in previously vaccinated SARS-CoV-1 survivors and naïve healthy individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Bi-Nan, Zhu, Ka-Li, Cui, Xiao-Ming, Yao, Lin, Wang, Xue-Jun, Wang, Guo-Lin, Duan, Li-Jun, Qian, Aruna, Ma, Mai-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423872/
https://www.ncbi.nlm.nih.gov/pubmed/36049602
http://dx.doi.org/10.1016/j.clim.2022.109103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423872/
https://www.ncbi.nlm.nih.gov/pubmed/36049602
http://dx.doi.org/10.1016/j.clim.2022.109103

Ejemplares similares